Clinical Trials · NCT00856986
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 987
- Start date
- Mar 2009
- Locations
- 233 sites, 10 countries
- Primary endpoint
- Mean Change From Randomisation in Glycosylated Haemoglobin A1c (HbA1c) at Week 26.